Brendan Pang

1.1k total citations
30 papers, 648 citations indexed

About

Brendan Pang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Brendan Pang has authored 30 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Brendan Pang's work include Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Genomics and Rare Diseases (3 papers). Brendan Pang is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Genomics and Rare Diseases (3 papers). Brendan Pang collaborates with scholars based in Singapore, United Kingdom and United States. Brendan Pang's co-authors include Manuel Salto‐Tellez, Chee Wee Ong, Fredrik Petersson, Richie Soong, Edison T. Liu, Michael A. Black, Kartiki V. Desai, Barry Iacopetta, Lance D. Miller and Benedict Yan and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Brendan Pang

30 papers receiving 640 citations

Peers

Brendan Pang
Ramona Erber Germany
Eun Hee Lee South Korea
Anca Oniscu United Kingdom
Linda Moskovszky Switzerland
Corrado Minimo United States
Ramona Erber Germany
Brendan Pang
Citations per year, relative to Brendan Pang Brendan Pang (= 1×) peers Ramona Erber

Countries citing papers authored by Brendan Pang

Since Specialization
Citations

This map shows the geographic impact of Brendan Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brendan Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brendan Pang more than expected).

Fields of papers citing papers by Brendan Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brendan Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brendan Pang. The network helps show where Brendan Pang may publish in the future.

Co-authorship network of co-authors of Brendan Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Brendan Pang. A scholar is included among the top collaborators of Brendan Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brendan Pang. Brendan Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pang, Brendan, Yong‐Guan Zhu, Jing Ni, et al.. (2020). Quality Assessment and Comparison of Plasma-Derived Extracellular Vesicles Separated by Three Commercial Kits for Prostate Cancer Diagnosis. SHILAP Revista de lepidopterología. 1 indexed citations
2.
Hoppe, Michał Marek, Teena Thakur, Henry Yang, et al.. (2020). Profiling of gastric cancer cell-surface markers to achieve tumour–normal discrimination. BMJ Open Gastroenterology. 7(1). e000452–e000452. 9 indexed citations
3.
Palafox, Marta, Touati Benoukraf, Patrick Jaynes, et al.. (2018). Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies. The Journal of Experimental Medicine. 215(7). 1913–1928. 44 indexed citations
4.
Hynes, Seán O., Brendan Pang, Jacqueline A. James, Perry Maxwell, & Manuel Salto‐Tellez. (2017). Tissue-based next generation sequencing: application in a universal healthcare system. British Journal of Cancer. 116(5). 553–560. 27 indexed citations
5.
Jain, Suneil, C. Lyons, Steven M. Walker, et al.. (2017). A metastatic biology gene expression assay to predict the risk of distant metastases in patients with localized prostate cancer treated with primary radical treatment.. Journal of Clinical Oncology. 35(6_suppl). 11–11. 2 indexed citations
6.
Yeo, Jin Fei, et al.. (2014). An intraosseous sclerosing odontogenic tumor predominantly composed of epithelial cells: relation to (so-called) sclerosing odontogenic carcinoma and epithelial-rich central odontogenic fibroma. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 118(4). e119–e125. 34 indexed citations
7.
Wong, Soon Boon Justin, et al.. (2014). Angiomatoid Fibrous Histiocytoma With Prominent Myxoid Stroma. American Journal of Dermatopathology. 37(8). 623–631. 7 indexed citations
8.
Jeyasekharan, Anand D., Kuangwen Hsieh, Koji Ichiyama, et al.. (2014). Combination of vaccine-strain measles and mumps virus synergistically kills a wide range of human hematological cancer cells: Special focus on acute myeloid leukemia. Cancer Letters. 354(2). 272–280. 15 indexed citations
9.
Loh, Marie, Natalia Liem, Nur Sabrina Sapari, et al.. (2014). DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach. BMC Gastroenterology. 14(1). 55–55. 34 indexed citations
10.
Lim, Joline S.J., Andrea Li Ann Wong, Ross A. Soo, et al.. (2014). Extended cohort study of OPB51602, a novel inhibitor of STAT3/5 activation, in non-small cell lung carcinoma.. Journal of Clinical Oncology. 32(15_suppl). 8028–8028. 2 indexed citations
11.
Pang, Brendan, Mary Beth Durso, Ronald L. Hamilton, & Marina N. Nikiforova. (2013). A Novel COLD-PCR/FMCA Assay Enhances the Detection of Low-abundance IDH1 Mutations in Gliomas. Diagnostic Molecular Pathology. 22(1). 28–34. 12 indexed citations
12.
Pang, Brendan, Chee Wee Ong, Seema Gupta, et al.. (2012). The positive impact of cytological specimens for EGFR mutation testing in non‐small cell lung cancer: a single South East Asian laboratory’s analysis of 670 cases. Cytopathology. 23(4). 229–236. 39 indexed citations
13.
Dettmer, Matthias S., Juergen Hench, Brendan Pang, Niels Willi, & Gieri Cathomas. (2012). Rhabdoid Large Cell Carcinoma of Lung, With Illustrative Immunohistochemical and Molecular Findings. Applied immunohistochemistry & molecular morphology. 20(3). 208–213. 5 indexed citations
14.
Ku, Chee‐Seng, Mengchu Wu, D.N. Cooper, et al.. (2012). Technological advances in DNA sequence enrichment and sequencing for germline genetic diagnosis. Expert Review of Molecular Diagnostics. 12(2). 159–173. 12 indexed citations
15.
Ong, Chee Wee, et al.. (2012). KIT gene mutation analysis in solid tumours: biology, clincial applications and trends in diagnostic reporting. Pathology. 45(2). 127–137. 10 indexed citations
16.
18.
Petersson, Fredrik, Brendan Pang, Thomas Paulraj Thamboo, & Thomas Choudary Putti. (2010). Mucinous cystadenocarcinoma of the breast with amplification of the HER2-gene confirmed by FISH: The first case reported. Human Pathology. 41(6). 910–913. 23 indexed citations
19.
Pang, Brendan, Chee Leong Cheng, Manuel Salto‐Tellez, & Fredrik Petersson. (2010). Desmoplastic Small Round Cell Tumor of Major Salivary Glands. Applied immunohistochemistry & molecular morphology. 19(1). 70–75. 20 indexed citations
20.
Lim, Geok Hoon, et al.. (2008). Cholesterol Atheroembolism of the Colon can Mimic the Endoscopic Features of Pseudomembranous Colitis. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 18(6). 616–618. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026